First patient in Arizona treated with new immune-cell therapy at HonorHealth Research Institute
SCOTTSDALE, Ariz. — Dec. 11, 2025 — A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the first in Arizona treated with a new immune-cell-therapy known as TECELRA at the HonorHealth Research Institute.
This new cell therapy targets a protein associated with the MAGEA4 gene, which is commonly expressed in synovial sarcoma and often occurs in the extremities, such as in the knees, though it can occur almost anywhere in the body.
“The patient tolerated the cell infusion well, with early signs of tumor shrinkage,” said Justin Moser, M.D., an associate clinical ...